Abstract
Exposure to traffic-related air pollutants has been associated with increased risk of adverse cardiopulmonary outcomes and mortality; however, the biochemical pathways linking exposure to disease are not known. To delineate biological response mechanisms associated with exposure to near-highway ultrafine particles (UFP), we used untargeted high-resolution metabolomics to profile plasma from 59 participants enrolled in the Community Assessment of Freeway Exposure and Health (CAFEH) study. Metabolic variations associated with UFP exposure were assessed using a cross-sectional study design based upon low (mean 16,000 particles/cm3) and high (mean 24,000 particles/cm3) annual average UFP exposures. In comparing quantified metabolites, we identified five metabolites that were differentially expressed between low and high exposures, including arginine, aspartic acid, glutamine, cystine and methionine sulfoxide. Analysis of the metabolome identified 316 m/z features associated with UFP, which were consistent with increased lipid peroxidation, endogenous inhibitors of nitric oxide and vehicle exhaust exposure biomarkers. Network correlation analysis and metabolic pathway enrichment identified 38 pathways and included variations related to inflammation, endothelial function and mitochondrial bioenergetics. Taken together, these results suggest UFP exposure is associated with a complex series of metabolic variations related to antioxidant pathways, in vivo generation of reactive oxygen species and processes critical to endothelial function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.
Di Q, Wang Y, Zanobetti A, Wang Y, Koutrakis P, Choirat C, et al. Air pollution and mortality in the medicare population. N Eng J Med. 2017;376:2513–22.
Zuurbier M, Hoek G, Oldenwening M, Meliefste K, van den Hazel P, Brunekreef B. Respiratory effects of commuters’ exposure to air pollution in traffic. Epidemiology. 2011;22:219–27.
Fuller CH, Williams PL, Mittleman MA, Patton AP, Spengler JD, Brugge D. Response of biomarkers of inflammation and coagulation to short-term changes in central site, local, and predicted particle number concentrations. Ann Epidemiol. 2015;25:505–11.
Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med. 2009;179:572–8.
Chu JH, Hart JE, Chhabra D, Garshick E, Raby BA, Laden F. Gene expression network analyses in response to air pollution exposures in the trucking industry. Environ Health. 2016;15:101.
Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res. 2013;41:D801–7.
Liu KH, Walker DI, Uppal K, Tran V, Rohrbeck P, Mallon TM, et al. High resolution metabolomics assessment of military personnel. J Occup Environ Med. 2016;58(8 Suppl 1):S53–61.
Breitner S, Schneider A, Devlin RB, Ward-Caviness CK, Diaz-Sanchez D, Neas LM, et al. Associations among plasma metabolite levels and short-term exposure to PM2.5 and ozone in a cardiac catheterization cohort. Environ Int. 2016;97:76–84.
Surowiec I, Karimpour M, Gouveia-Figueira S, Wu J, Unosson J, Bosson JA, et al. Multi-platform metabolomics assays for human lung lavage fluids in an air pollution exposure study. Anal Bioanal Chem. 2016;408:4751–64.
Vlaanderen JJ, Janssen NA, Hoek G, Keski-Rahkonen P, Barupal DK, Cassee FR, et al. The impact of ambient air pollution on the human blood metabolome. Environ Res. 2017;156:341–8.
Pradhan SN, Das A, Meena R, Nanda RK, Rajamani P. Biofluid metabotyping of occupationally exposed subjects to air pollution demonstrates high oxidative stress and deregulated amino acid metabolism. Sci Rep. 2016;6:35972.
Menni C, Metrustry SJ, Mohney RP, Beevers S, Barratt B, Spector TD, et al. Circulating levels of antioxidant vitamins correlate with better lung function and reduced exposure to ambient pollution. Am J Respir Crit Care Med. 2015;191:1203–7.
Lane KJ, Levy JI, Scammell MK, Peters JL, Patton AP, Reisner E, et al. Association of modeled long-term personal exposure to ultrafine particles with inflammatory and coagulation biomarkers. Environ Int. 2016;92-93:173–82.
Fuller CH, Patton AP, Lane K, Laws MB, Marden A, Carrasco E, et al. A community participatory study of cardiovascular health and exposure to near-highway air pollution: study design and methods. Rev Environ Health. 2013;28:21–35.
Patton AP, Zamore W, Naumova EN, Levy JI, Brugge D, Durant JL. Transferability and generalizability of regression models of ultrafine particles in urban neighborhoods in the Boston area. Environ Sci Technol. 2015;49:6051–60.
Lane KJ, Levy JI, Scammell MK, Patton AP, Durant JL, Mwamburi M, et al. Effect of time-activity adjustment on exposure assessment for traffic-related ultrafine particles. J Expo Sci Environ Epidemiol. 2015;25:506–16.
Patton AP, Perkins J, Zamore W, Levy JI, Brugge D, Durant JL. Spatial and temporal differences in traffic-related air pollution in three urban neighborhoods near an interstate highway. Atmos Environ. 1994;2014:309–21.
Lane KJ, Kangsen Scammell M, Levy JI, Fuller CH, Parambi R, Zamore W, et al. Positional error and time-activity patterns in near-highway proximity studies: an exposure misclassification analysis. Environ Health. 2013;12:75.
Fuller CH, Brugge D, Williams PL, Mittleman MA, Lane K, Durant JL, et al. Indoor and outdoor measurements of particle number concentration in near-highway homes. J Expo Sci Environ Epidemiol. 2013;23:506–12.
Soltow QA, Strobel FH, Mansfield KG, Wachtman L, Park Y, Jones DP. High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome. Metabolomics. 2013;9:S132–S143.
Liu KH, Walker DI, Uppal K, Tran V, Rohrbeck P, Mallon TM, et al. High-resolution metabolomics assessment of military personnel: evaluating analytical strategies for chemical detection. J Occup Environ Med / Am Coll Occup Environ Med. 2016;58:S53–61.
Yu T, Park Y, Li S, Jones DP. Hybrid feature detection and information accumulation using high-resolution LC-MS metabolomics data. J Proteome Res. 2013;12:1419–27.
Uppal K, Soltow QA, Strobel FH, Pittard WS, Gernert KM, Yu T, et al. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinforma. 2013;14:15.
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27.
Go YM, Walker DI, Liang Y, Uppal K, Soltow QA, Tran V, et al. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol Sci. 2015;148:531–43.
Simon-Manso Y, Lowenthal MS, Kilpatrick LE, Sampson ML, Telu KH, Rudnick PA, et al. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal Chem. 2013;85:11725–31.
Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51:3299–305.
Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol. 2014;307:C39–54.
CDC, NCHS. Laboratory Data: Brominated Flame Retardants (BFRs), Non-dioxin-like Polychlorinated Biphenyls, Fatty Acids - Plasma; Year 2003-2004. In: National Health and Nutrition Examination Survey Data, Year 2003-2004. August 2007, April 2008 ed. https://wwwn.cdc.gov/nchs/nhanes/Search/DataPage.aspx?Component=Laboratory&CycleBeginYear=2003; Accessed 21 Jan 2017: Centers for Disease Control and Prevention; National Center for Health Statistics.
Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst. 2001;58:109–30.
Boulesteix A, Durif G, Labmbert-Lacroix S, Peyre J, Strimmer K. plsgenomics: PLS Analyses for Genomics. In. R package version 1.3-2. https://CRAN.R-project.org/package=plsgenomics ed, 2017.
Rohart F, Gautier B, Singh A, Le Cao KA. mixOmics: an R package for ‘omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13:e1005752.
Schymanski EL, Jeon J, Gulde R, Fenner K, Ruff M, Singer HP, et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol. 2014;48:2097–8.
Uppal K, Walker DI, Jones DP. xMSannotator: an R package for network-based annotation of high-resolution metabolomics data. Analytical chemistry 2016; https://doi.org/10.1021/acs.analchem.6b01214.
Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27:747–51.
Uppal K, Walker DI, Liu K, Li S, Go YM, Jones DP. Computational metabolomics: a framework for the million metabolome. Chemical research in toxicology 2016; https://doi.org/10.1021/acs.chemrestox.6b00179.
Uppal K, Soltow QA, Promislow DE, Wachtman LM, Quyyumi AA, Jones DP. MetabNet: an R package for metabolic association analysis of high-resolution metabolomics data. Front Bioeng Biotechnol. 2015;3:87.
Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57:289–300.
Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with cytoscape 3. Curr Protoc Bioinforma. 2014;47:8 13 11-18 13 24.
Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, et al. Predicting network activity from high throughput metabolomics. PLoS Comput Biol. 2013;9:e1003123.
Go YM, Jones DP. Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med. 2011;50:495–509.
Iyer SS, Accardi CJ, Ziegler TR, Blanco RA, Ritzenthaler JD, Rojas M, et al. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS ONE. 2009;4:e5017.
Go YM, Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation. 2005;111:2973–80.
Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, et al. Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension. 2008;52:80–5.
Moskovitz J, Berlett BS, Poston JM, Stadtman ER. The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci USA. 1997;94:9585–9.
Mashima R, Nakanishi-Ueda T, Yamamoto Y. Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry. Anal Biochem. 2003;313:28–33.
Ligthart-Melis GC, van de Poll MC, Boelens PG, Dejong CH, Deutz NE, van Leeuwen PA. Glutamine is an important precursor for de novo synthesis of arginine in humans. Am J Clin Nutr. 2008;87:1282–9.
Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004;134:2880S–2887S. discussion 2895S
Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10:4–18.
Accardi CJ, Walker DI, Uppal K, Quyyumi AA, Rohrbeck P, Pennell KD, et al. High-resolution metabolomics for nutrition and health assessment of armed forces personnel. J Occup Environ Med. 2016;58:S80–8.
Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111:5944–72.
Lodovici M, Bigagli E. Oxidative stress and air pollution exposure. J Toxicol. 2011;2011:487074.
Bates JT, Weber RJ, Abrams J, Verma V, Fang T, Klein M, et al. Reactive oxygen species generation linked to sources of atmospheric particulate matter and cardiorespiratory effects. Environ Sci Technol. 2015;49:13605–12.
Weber D, Milkovic L, Bennett SJ, Griffiths HR, Zarkovic N, Grune T. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol. 2013;1:226–33.
Akude E, Zherebitskaya E, Roy Chowdhury SK, Girling K, Fernyhough P. 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res. 2010;17:28–38.
Selley ML. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson’s disease. Free Radic Biol Med. 1998;25:169–74.
Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6:82–90.
Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation. 2003;108:933–8.
Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism. 2004;53:1574–9.
Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol. 2006;17:1128–34.
Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 2004;49:397–414.
Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem. 1998;44:1833–43.
Chung MK, Riby J, Li H, Iavarone AT, Williams ER, Zheng Y, et al. A sandwich enzyme-linked immunosorbent assay for adducts of polycyclic aromatic hydrocarbons with human serum albumin. Anal Biochem. 2010;400:123–9.
Delaney JC, Essigmann JM. Biological properties of single chemical-DNA adducts: a twenty year perspective. Chem Res Toxicol. 2008;21:232–52.
Sobinoff AP, Mahony M, Nixon B, Roman SD, McLaughlin EA. Understanding the Villain: DMBA-induced preantral ovotoxicity involves selective follicular destruction and primordial follicle activation through PI3K/Akt and mTOR signaling. Toxicol Sci. 2011;123:563–75.
ATSDR. Toxicological Profile for Cresols. Atlanta, GA: Agency for Toxic Substances and Disease Registry, Division of Toxicology and Environmental Medicine/Applied Toxicology Branch; 2008.
Chonchol M, Nielson C. Hemoglobin levels and coronary artery disease. Am Heart J. 2008;155:494–8.
Walker DI, Go Y, Liu K, Pennell K, Jones D, editors. Population screening for biological and environmental properties of the human metabolic phenotype: Implications for personalized medicine. Elsevier, San Diego, CA, USA, 2016.
Acknowledgements
This work was supported by funds received from the National Institute of Health, award numbers ES019776, ES023485, ES025632, ES015462, and OD018006. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the views and policies of the EPA or motor vehicle and engine manufacturers.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Supplementary Information
Rights and permissions
About this article
Cite this article
Walker, D.I., Lane, K.J., Liu, K. et al. Metabolomic assessment of exposure to near-highway ultrafine particles. J Expo Sci Environ Epidemiol 29, 469–483 (2019). https://doi.org/10.1038/s41370-018-0102-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41370-018-0102-5
Keywords
This article is cited by
-
Standardizing non-targeted analysis reporting to advance exposure science and environmental epidemiology
Journal of Exposure Science & Environmental Epidemiology (2023)
-
Maternal and newborn metabolomic changes associated with urinary polycyclic aromatic hydrocarbon metabolite concentrations at delivery: an untargeted approach
Metabolomics (2023)
-
Malondialdehyde and anion patterns in exhaled breath condensate among subway workers
Particle and Fibre Toxicology (2022)
-
Sphinganine is associated with 24-h MAP in the non-sleepy with OSA
Metabolomics (2022)
-
Mixture toxicity, cumulative risk, and environmental justice in United States federal policy, 1980–2016
Environmental Health (2021)